5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.37▼ | 3.36▼ | 3.36▼ | 3.52▼ | 3.24▲ |
MA10 | 3.37▼ | 3.38▼ | 3.45▼ | 3.35▼ | 3.49▼ |
MA20 | 3.37▼ | 3.46▼ | 3.51▼ | 3.25▲ | 4.94▼ |
MA50 | 3.37▼ | 3.53▼ | 3.45▼ | 3.72▼ | 7.61▼ |
MA100 | 3.44▼ | 3.42▼ | 3.30▲ | 5.23▼ | 8.00▼ |
MA200 | 3.50▼ | 3.28▲ | 3.30▲ | 7.51▼ | 10.77▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.011▼ | -0.033▼ | 0.082▲ | -0.029▼ |
RSI | 33.939▼ | 31.718▼ | 35.179▼ | 46.406▼ | 31.865▼ |
STOCH | 60.880 | 12.416▼ | 13.537▼ | 81.562▲ | 16.049▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -42.484 | -83.421▼ |
CCI | -200.197▼ | -86.897 | -110.491▼ | 44.844 | -52.755 |
Wednesday, April 30, 2025 05:14 AM
Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs, but this hasn't translated into strong performances recently. Here's why Iovance ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 3.60 | 3.60 | 3.32 | 3.33 | 10,863,000 |
30/04/25 | 3.44 | 3.63 | 3.405 | 3.59 | 6,997,873 |
29/04/25 | 3.645 | 3.655 | 3.545 | 3.56 | 5,769,783 |
28/04/25 | 3.54 | 3.65 | 3.49 | 3.61 | 6,495,200 |
25/04/25 | 3.32 | 3.64 | 3.25 | 3.51 | 14,758,500 |
24/04/25 | 3.22 | 3.37 | 3.18 | 3.36 | 5,662,700 |
23/04/25 | 3.34 | 3.43 | 3.17 | 3.19 | 7,088,700 |
22/04/25 | 3.12 | 3.22 | 3.04 | 3.21 | 8,928,300 |
21/04/25 | 3.06 | 3.35 | 2.98 | 3.08 | 9,639,000 |
17/04/25 | 3.05 | 3.09 | 2.89 | 3.06 | 9,646,000 |
|
|
||||
|
|
||||
|
|